Jayaram Bharadwaj, MD

home / authors / jayaram-bharadwaj-md

Articles

Superior Mesenteric Vein Thrombosis

Superior Mesenteric Vein Thrombosis

Jayaram Bharadwaj, MD;Vineeta Baranos, MD;Rakesh Shrivastava, MD;Michael Disalle, MD;David Wolf, MD;James Haley, MD
September 14th 2005

A 65-year-old woman with metastatic adenocarcinoma of the colon was undergoing chemotherapy following a colectomy and a hepatic wedge resection. The physical examination and laboratory data were unremarkable.

Superior Mesenteric Vein Thrombosis and Abdominal Pain

Superior Mesenteric Vein Thrombosis and Abdominal Pain

Jayaram Bharadwaj, MD
April 2nd 2002

A 65-year-old woman with metastatic adenocarcinoma of the colon was undergoing chemotherapy following a colectomy and a hepatic wedge resection. The physical examination and laboratory data were unremarkable.

Latest Updated Articles

Ruxolitinib Cream 1.5% Demonstrates Efficacy in Prurigo Nodularis: Phase 3 Findings
Published: March 8th 2025 | Updated: March 12th 2025
Ruxolitinib Cream 1.5% Demonstrates Efficacy in Prurigo Nodularis: Phase 3 Findings
Rocatinlimab Shows Significant Efficacy in Moderate to Severe Atopic Dermatitis: Phase 3 IGNITE Trial Results / image credit ©MQ-Illustrations/ stock.adobe.com
Published: March 8th 2025 | Updated: March 12th 2025
Rocatinlimab Shows Significant Efficacy in Moderate to Severe Atopic Dermatitis: Phase 3 IGNITE Trial Results
Icotrokinra Shows Promise for Moderate-to-Severe Plaque Psoriasis in Phase 3 Trials
Published: March 8th 2025 | Updated: March 12th 2025
Icotrokinra Shows Promise for Moderate-to-Severe Plaque Psoriasis in Phase 3 Trials
Tapinarof Cream 1% Demonstrates Sustained Disease Control in Adults, Children with Atopic Dermatitis
Published: March 8th 2025 | Updated: March 12th 2025
Tapinarof Cream 1% Demonstrates Sustained Disease Control in Adults, Children with Atopic Dermatitis
Lebrikizumab Shows Promise for Atopic Dermatitis Among Adults and Adolescents Previously Treated with Dupilumab
Published: March 8th 2025 | Updated: March 12th 2025
Lebrikizumab Improves Patient-Reported Outcomes in Atopic Dermatitis for Patients Previously Treated with Dupilumab
Ruxolitinib Cream Demonstrates Long-Term Disease Control in Atopic Dermatitis
Published: March 7th 2025 | Updated: March 12th 2025
Ruxolitinib Cream Demonstrates Long-Term Disease Control in Atopic Dermatitis
© 2025 MJH Life Sciences

All rights reserved.